From: Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
Group I (stable), N = 26 | Group II (exacerbation), N = 47 | Group III (healthy control), N = 15 | P value | |||
---|---|---|---|---|---|---|
Group I and II | Group I and III | Group II and III | ||||
Age (years) | ||||||
Mean ± SD | 51.03 ± 14.47 | 54.80 ± 15.06 | 41.73 ± 13.01 | 0.293 | 0.052 | 0.062 |
Range | 23–89 | 21–85 | 27–66 | |||
Sex, n (%) | ||||||
Males | 4 (15.4%) | 10 (21.3%) | 6 (40%) | 0.542 | 0.081 | 0.153 |
Females | 22 (84.6%) | 37 (78.7%) | 9 (60%) | |||
Smoking | ||||||
Yes | 2 (7.7%) | 2 (4.3%) | 0 (0%) | 0.860 | 0.114 | 0.089 |
No | 22 (84.6%) | 39 (83%) | 15 (100%) | |||
Ex | 2 (7.7%) | 6 (12.8%) | 0 (0%) |